arrow
M

Mafalda Santiago

centro hospitalar e universitario de coimbra (chuc)
H指数:13
被引数:361

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Soluble transferrin receptor as a reliable inflammation-independent marker of iron deficiency in Crohn’s disease and ulcerative colitis

可溶性转铁蛋白受体作为克罗恩病和溃疡性结肠炎中铁缺乏的可靠且与炎症无关的标志物

2026-05-090
PRE
Salivary microbiota dysbiosis in Inflammatory Bowel Disease: impact of 5-ASA and oral inflammation

炎症性肠病中的唾液微生物群失调:5-ASA和口腔炎症的影响

2026-01-010
PRE
Establishing a multiple outcome set for Crohn's disease in real-world evidence studies: results from a Delphi e-survey

为克罗恩病真实世界证据研究建立多结局集:德尔菲电子调查的结果

2025-10-010
PRE
Longitudinal profiles of fecal calprotectin and C-reactive protein in relation to outcomes in Crohn's disease patients on infliximab

克罗恩病患者在英夫利昔单抗治疗期间,粪钙卫蛋白和C反应蛋白的纵向变化与治疗结局的关系

2025-08-011
PRE
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab
2024-05-011
OAAI
The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients
2024-01-192
PRE
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study
2023-06-155
OAAI
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta-analysis

克罗恩病随机对照试验是否已达到治疗上限?系统综述与meta分析

2023-03-0618
OAAI
Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years
2022-09-018
OAAI
Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy
2021-12-0119
PREAI